6th Annual Biomedical Forum

When: April 30th, 2011 (Saturday); 9:00 am – 4:30 pm

Where: McDonnell Douglas Auditorium, UC Irvine

Registration: http://sabpa.org/web/OCLA

The upcoming annual biomedical forum will focus on FDA regulatory issues and the latest innovations in medical devices industries. The biomedical forum strives to provide an attractive platform for entrepreneurs, scientists, engineers, investors, executives, and policy makers to promote life sciences, biotech, medical device and alliances across the biomedical industry in Southern California and Asia.

Program

8:00 am Registration, Coffee and Breakfast

9:00 am Opening Remarks, Fred Ouyang, PhD, MBA, President, SABPA OC/LA

Session 1 Innovation in Medical Device

Moderator: Peter Chen PhD, President, Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc.

9:15 am Thomas Yuen, Chairman and CEO, SRS Labs, Biomedical Entrepreneur

“Exploring the therapeutic application of stem cell technology: an entrepreneur’s journey”

10:00 am Fred Tzeng, PhD, President and Co-founder, ZeroWatt Technologies

“Commercialization of University Research by a Former Grad Student”

10:20 am Break

10:40 am Paul Chen, MD,Entrepreneur and Eye Surgeon, North County Laser Eye Associates at San Diego

“JET Lasik, accelerating ocular healing by cell transplantation”

11:00 am Steve Wheeler, Director of Sales, IDEAL LIFE

“The World-Wide Opportunities for Customized Wireless Monitoring with Real Time Data Access”

11:20 am Nadine Ding, PhD, Fellow at Abbott Vascular Devices

“'Drug Eluting Stent, a Combination Product of Drug and Device and Its Regulatory Pathway”

11:40 am Lunch and Exhibit Booth

Session II Industry

Moderator: Jinsong Ni, PhD, Director, Drug Safety Evaluation, Allergan Inc

1: 00 pm Edwards Sydney, Senior Director, Portfolio Management and Strategic Planning, Allergan

“Global Project & Portfolio Management: The Allergan Experience”

1:20 pm Sabing Lee, JD, Knobbe, Martens, Olson & Bear, LLP

"Important Developments in Intellectual Property Affecting the Biomedical and Pharmaceutical Industries"

1:40 pm Jerry Hefner, Ph.D., J.D., Partner, Knobbe Martens Olson & Bear LLP

"Potential Changes in the Patentability of Life Science Inventions"

2:00 pm Abe Lee, Chair and Professor, Department of Biomedical Engineering, UCI

"Microfluidic Delivery of Medicine: from point-of-care diagnostics to targeted therapeutics"

2:20 pm Frank Jaksch, CEO ChromaDex

“The Next Super-Class of Phytochemical Ingredients for Nutraceuticals, Functional Food and Cosmetics”

2:40 pm

Break

Session III FDA Regulation of Biomedical Industry

Moderator: Yan-bo Yang, Director, Pharmaceutical Development, B. Braun Medical Inc.

3:00 pm

Shepard G. Bentley, RAC, Bentley & Liu Biomedical Consulting

“FDA Regulations and Chinese Manufacturers: The Challenges”

3:20 pm

Jeff Yuen, MPH, MBA, Previous FDA District Drug Team Leader and Drug Pre-Approval Manager, President and CEO, Jeff Yuen & Associates

“Recent FDA Regulatory Trends and Compliance Issues”

3: 40 pm

Alonza Cruse, Director, Los Angeles District Office, US FDA

"A FDA Regulatory (Compliance) Update - A Los Angeles District Perspective"

4:25 pm Closing Remark

Hengchu Cao, Ph.D. Edwards Life Ssciences, Past President, SABPA OC/LA